1253 Results

People

  1. Motzer
    Motzer
  2. Kingham
    Kingham
  3. Hudis
    Hudis
  4. Abou-Alfa
    Abou-Alfa
  5. Horwitz
    Horwitz
  6. Zelenetz
    Zelenetz
  7. Kris
    Kris
  8. Perales
    Perales
  9. Aghajanian
    Aghajanian
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)
  7. Population Sciences Research Program (170)
  8. Epidemiology and Biostatistics (122)
  9. Center for Pancreatic Cancer Research (110)
  10. Genitourinary Oncology Service (109)
  1. "multicenter study"
Formats
  1. Journal Article (1219)
  2. Research Letter (12)
  3. Conference Paper (7)
  4. Correspondence (6)
  5. Review (5)
  6. Guidelines (2)
  7. Editorial (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)

More Groups

People
  1. Robert Motzer (47)
  2. T Peter Kingham (31)
  3. Clifford Hudis (19)
  4. Andrew Zelenetz (18)
  5. Ghassan Abou-Alfa (18)
  6. Steven Horwitz (18)

More People

Years
  1. 2025 (86)
  2. 2024 (191)
  3. 2023 (130)
  4. 2022 (83)
  5. 2021 (50)
  6. 2020 (63)

More Years

Publications
  1. Journal of Clinical Oncology (118)
  2. Lancet Oncology (57)
  3. New England Journal of Medicine (56)
  4. Clinical Cancer Research (46)
  5. Blood (44)
  6. Cancer (36)

More Publications

Publishers
  1. Elsevier Inc. (152)
  2. Elsevier Science, Inc. (137)
  3. American Society of Clinical Oncology (124)
  4. Springer (84)
  5. Oxford University Press (79)
  6. Wiley Blackwell (71)

More Publishers

Results (1253)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): A multicentre, single-arm, phase 2 study
    Journal Article

    Balar, A. V.; Castellano, D.; O'Donnell, P. H.; Grivas, P.; Vuky, J.; Powles, T.; Plimack, E. R.; Hahn, N. M.; de Wit, R.; Pang, L.; more...
    Lancet Oncology (2017)

    Fulltext@MSK | Save
  • Association of fat grafting with patient-reported outcomes in postmastectomy breast reconstruction
    Journal Article

    Bennett, K. G.; Qi, J.; Kim, H. M.; Hamill, J. B.; Wilkins, E. G.; Mehrara, B. J.; Kozlow, J. H.
    JAMA Surgery (2017)

    Fulltext@MSK | Save
  • Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma
    Journal Article

    Geoerger, B.; Bergeron, C.; Gore, L.; Sender, L.; Dunkel, I. J.; Herzog, C.; Brochez, L.; Cruz, O.; Nysom, K.; Berghorn, E.; more...
    European Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Biochemical control during long-term follow-up of 230 adult patients with Cushing disease: A multicenter retrospective study
    Journal Article

    Geer, E. B.; Shafiq, I.; Gordon, M. B.; Bonert, V.; Ayala, A.; Swerdloff, R. S.; Katznelson, L.; Lalazar, Y.; Manuylova, E.; Pulaski-Liebert, K. J.; more...
    Endocrine Practice (2017)

    Fulltext@MSK | Save
  • Signs of facial aging in men in a diverse, multinational study: Timing and preventive behaviors
    Journal Article

    Rossi, A. M.; Eviatar, J.; Green, J. B.; Anolik, R.; Eidelman, M.; Keaney, T. C.; Narurkar, V.; Jones, D.; Kolodziejczyk, J.; Drinkwater, A.; more...
    Dermatologic Surgery (2017)

    Fulltext@MSK | Save
  • Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): A multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
    Journal Article

    Kim, S. B.; Dent, R.; Im, S. A.; EspieĢ, M.; Blau, S.; Tan, A. R.; Isakoff, S. J.; Oliveira, M.; Saura, C.; Wongchenko, M. J.; more...
    Lancet Oncology (2017)

    Fulltext@MSK | Save
  • Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): A multicentre, two-cohort, single-arm, open-label, phase 2 trial
    Journal Article

    Tawbi, H. A.; Burgess, M.; Bolejack, V.; Van Tine, B. A.; Schuetze, S. M.; Hu, J.; D'Angelo, S.; Attia, S.; Riedel, R. F.; Priebat, D. A.; more...
    Lancet Oncology (2017)

    Fulltext@MSK | Save
  • Bevacizumab for advanced cervical cancer: Final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
    Journal Article

    Tewari, K. S.; Sill, M. W.; Penson, R. T.; Huang, H.; Ramondetta, L. M.; Landrum, L. M.; Oaknin, A.; Reid, T. J.; Leitao, M. M.; Michael, H. E.; more...
    Lancet (2017)

    Fulltext@MSK | Save
  • Molecular analyses reveal inflammatory mediators in the solid component and cyst fluid of human adamantinomatous craniopharyngioma
    Journal Article

    Donson, A. M.; Apps, J.; Griesinger, A. M.; Amani, V.; Witt, D. A.; Anderson, R. C. E.; Niazi, T. N.; Grant, G.; Souweidane, M.; Johnston, J. M.; more...
    Journal of Neuropathology and Experimental Neurology (2017)

    Fulltext@MSK | Save
  • Prospective trial evaluating the surgical anastomosis at one-year colorectal cancer surveillance: CT colonography versus optical colonoscopy and implications for patient care
    Journal Article

    Pickhardt, P. J.; Edwards, K.; Bruining, D. H.; Gollub, M.; Kupfer, S.; Lubner, S. J.; Kim, D. H.; Ross, E.; Keenan, E.; Weinberg, D. S.
    Diseases of the Colon and Rectum (2017)

    Fulltext@MSK | Save